{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T06:53:32Z","timestamp":1775631212367,"version":"3.50.1"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100012832","name":"Okinaka Memorial Institute for Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012832","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>A 61-year-old Japanese woman with a 20-year history of rheumatoid arthritis (RA) had been treated with various antirheumatic drugs, including biologics and Janus kinase inhibitors. Subcutaneous methotrexate (MTX) was added to sarilumab, resulting in improvement in her joint tenderness. Six months later, however, while continuing both agents, she developed exertional dyspnea. Computed tomography revealed bilateral ground-glass opacities, and transbronchial lung cryobiopsy (TBLC) showed pathological findings consistent with MTX-induced pneumonitis. She responded rapidly to glucocorticoids, but subsequently developed recurrent episodes of RA-associated organizing pneumonia despite discontinuation of MTX, which was evaluated by repeat bronchoscopy and supported the diagnosis of RA-associated organizing pneumonia, and prolonged glucocorticoid therapy was required. MTX-induced pneumonitis is a potentially life-threatening complication. This case demonstrates that subcutaneous MTX does not eliminate the risk of pneumonitis, that transbronchial lung cryobiopsy is a valuable diagnostic tool allowing clear pathological characterization with ample tissue to support confident pathologic diagnosis, and that the marked discrepancy in imaging supports that repeat bronchoscopy is warranted rather than avoided when new imaging points to an alternative diagnosis.<\/jats:p>","DOI":"10.1093\/mrcr\/rxag024","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T12:50:53Z","timestamp":1772628653000},"source":"Crossref","is-referenced-by-count":1,"title":["Transbronchial lung cryobiopsy-supported subcutaneous methotrexate-induced pneumonitis and subsequent rheumatoid arthritis organising pneumonias"],"prefix":"10.1093","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1494-3291","authenticated-orcid":false,"given":"Yuki","family":"Oba","sequence":"first","affiliation":[{"name":"Nephrology Center and Department of Rheumatology, Toranomon Hospital Kajigaya , Kawasaki, Kanagawa ,","place":["Japan"]},{"name":"Okinaka Memorial Institute for Medical Research , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifumi","family":"Ubara","sequence":"additional","affiliation":[{"name":"Nephrology Center and Department of Rheumatology, Toranomon Hospital Kajigaya , Kawasaki, Kanagawa ,","place":["Japan"]},{"name":"Okinaka Memorial Institute for Medical Research , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Miyamoto","sequence":"additional","affiliation":[{"name":"Okinaka Memorial Institute for Medical Research , Tokyo ,","place":["Japan"]},{"name":"Department of Respiratory Medicine, Respiratory Center, Toranomon Hospital , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamiko","family":"Takemura","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kanagawa Cardiovascular and Respiratory Center , Yokohama, Kanagawa ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Mizuno","sequence":"additional","affiliation":[{"name":"Nephrology Center and Department of Rheumatology, Toranomon Hospital Kajigaya , Kawasaki, Kanagawa ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Yamanouchi","sequence":"additional","affiliation":[{"name":"Nephrology Center and Department of Rheumatology, Toranomon Hospital Kajigaya , Kawasaki, Kanagawa ,","place":["Japan"]},{"name":"Okinaka Memorial Institute for Medical Research , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Suwabe","sequence":"additional","affiliation":[{"name":"Nephrology Center and Department of Rheumatology, Toranomon Hospital Kajigaya , Kawasaki, Kanagawa ,","place":["Japan"]},{"name":"Okinaka Memorial Institute for Medical Research , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Kono","sequence":"additional","affiliation":[{"name":"Department of Pathology, Toranomon Hospital , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironori","family":"Uruga","sequence":"additional","affiliation":[{"name":"Department of Pathology, Toranomon Hospital , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Takazawa","sequence":"additional","affiliation":[{"name":"Department of Pathology, Toranomon Hospital , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiyo","family":"Tamaoka","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Respiratory Center, Toranomon Hospital , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Sawa","sequence":"additional","affiliation":[{"name":"Nephrology Center and Department of Rheumatology, Toranomon Hospital Kajigaya , Kawasaki, Kanagawa ,","place":["Japan"]},{"name":"Okinaka Memorial Institute for Medical Research , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"key":"2026040802024261800_ref1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41584-020-0373-9","article-title":"Methotrexate and its mechanisms of action in inflammatory arthritis","volume":"16","author":"Cronstein","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"2026040802024261800_ref2","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1136\/annrheumdis-2014-205228","article-title":"Head-to-head, randomised, crossover study of oral versus subcutaneous methotrexate in patients with rheumatoid arthritis: drug-exposure limitations of oral methotrexate at doses &gt;\/=15 mg may be overcome with subcutaneous administration","volume":"73","author":"Schiff","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2026040802024261800_ref3","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/mr\/roac103","article-title":"Efficacy and tolerability of subcutaneously administered methotrexate including dose escalation in long-term treatment of rheumatoid arthritis in a Japanese population","volume":"33","author":"Tanaka","year":"2022","journal-title":"Mod Rheumatol"},{"key":"2026040802024261800_ref4","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/mr\/roaf006","article-title":"2024 update of the Japan college of rheumatology clinical practice guidelines for the Management of Rheumatoid Arthritis: secondary publication","volume":"35","author":"Harigai","year":"2025","journal-title":"Mod Rheumatol"},{"key":"2026040802024261800_ref5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/mr\/road098","article-title":"Japan College of Rheumatology guidance for the use of methotrexate in patients with rheumatoid arthritis: secondary publication","volume":"34","author":"Kameda","year":"2023","journal-title":"Mod Rheumatol"},{"key":"2026040802024261800_ref6","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1093\/rheumatology\/kez337","article-title":"Methotrexate and interstitial lung disease: controversies and questions. A narrative review of the literature","volume":"58","author":"Fragoulis","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"2026040802024261800_ref7","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1136\/ard.47.9.784","article-title":"Life threatening acute pneumonitis during low dose methotrexate treatment for rheumatoid arthritis: a case report and review of the literature","volume":"47","author":"Ridley","year":"1988","journal-title":"Ann Rheum Dis"},{"key":"2026040802024261800_ref8","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1034\/j.1399-3003.2000.15b25.x","article-title":"Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients","volume":"15","author":"Imokawa","year":"2000","journal-title":"Eur Respir J"},{"key":"2026040802024261800_ref9","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12890-023-02429-0","article-title":"Can transbronchial lung cryobiopsy benefit adaptive treatment strategies in connective tissue disease-associated interstitial lung disease?","volume":"23","author":"Yamakawa","year":"2023","journal-title":"BMC Pulm Med"},{"key":"2026040802024261800_ref10","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1007\/s10067-021-05671-1","article-title":"Transbronchial lung cryobiopsy for connective tissue disease-related interstitial lung disease and interstitial pneumonia with autoimmune features: a single center retrospective case series","volume":"40","author":"Wu","year":"2021","journal-title":"Clin Rheumatol"},{"key":"2026040802024261800_ref11","doi-asserted-by":"crossref","first-page":"107759","DOI":"10.1016\/j.rmed.2024.107759","article-title":"Diagnostic yield and safety of repeat bronchoscopy in pulmonary disease: a five-year retrospective analysis","volume":"232","author":"Uzer","year":"2024","journal-title":"Respir Med"},{"key":"2026040802024261800_ref12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1136\/ard.61.2.161","article-title":"Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment","volume":"61","author":"Ribbens","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"2026040802024261800_ref13","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.2169\/internalmedicine.50.5497","article-title":"A case of organizing pneumonia induced by tocilizumab","volume":"50","author":"Ikegawa","year":"2011","journal-title":"Intern Med"},{"key":"2026040802024261800_ref14","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1111\/bcp.14878","article-title":"Lung and liver sarcoidosis-like reaction induced by tocilizumab","volume":"87","author":"Lambert","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"2026040802024261800_ref15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3899\/jrheum.130466","article-title":"Effectiveness and safety of tocilizumab: Postmarketing surveillance of 7901 patients with rheumatoid arthritis in Japan","volume":"41","author":"Koike","year":"2014","journal-title":"J Rheumatol"},{"key":"2026040802024261800_ref16","doi-asserted-by":"crossref","first-page":"e0286191","DOI":"10.1371\/journal.pone.0286191","article-title":"Factors associated with interstitial lung disease in patients with rheumatoid arthritis: a systematic review and meta-analysis","volume":"18","author":"Zhang","year":"2023","journal-title":"PLoS One"},{"key":"2026040802024261800_ref17","doi-asserted-by":"crossref","first-page":"2332406","DOI":"10.1080\/07853890.2024.2332406","article-title":"The prevalence and risk factors of rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis","volume":"56","author":"Wang","year":"2024","journal-title":"Ann Med"}],"container-title":["Modern Rheumatology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mrcr\/advance-article-pdf\/doi\/10.1093\/mrcr\/rxag024\/67279410\/rxag024.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/10\/1\/rxag024\/67279410\/rxag024.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/10\/1\/rxag024\/67279410\/rxag024.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T06:02:50Z","timestamp":1775628170000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mrcr\/article\/doi\/10.1093\/mrcr\/rxag024\/8512088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,6]]}},"URL":"https:\/\/doi.org\/10.1093\/mrcr\/rxag024","relation":{},"ISSN":["2472-5625"],"issn-type":[{"value":"2472-5625","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026]]},"published":{"date-parts":[[2026]]},"article-number":"rxag024"}}